Sk Biopharmaceuticals Co., Ltd.

Sk Biopharmaceuticals Co., Ltd. is a leading biomedical company primarily engaged in the research, development, and commercialization of innovative pharmaceutical products. This company operates with a strong focus on central nervous system (CNS) disorders, aiming to address unmet medical needs through its proprietary drug development programs. One of its notable achievements includes the development of therapies for epilepsy and Parkinson's disease, which highlights its commitment to advancing treatments in the CNS sector. Additionally, Sk Biopharmaceuticals is actively expanding its portfolio through strategic partnerships and collaborations in the biopharmaceutical industry. By leveraging advanced research facilities and a robust pipeline of clinical stage assets, the company plays a significant role in contributing to the pharmaceutical market's landscape. Its presence is crucial in enhancing the availability of targeted therapies, ultimately improving patient outcomes across global healthcare systems.

CEO

이동훈

Employees

246

Website

skbp.com